SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Brawn Biotech informs about non applicability for filing of related party disclosures

16 Nov 2023 Evaluate
Brawn Biotech has informed that the company had a Paid-up Share Capital of Rs 3,00,03,000 and Net Worth of Rs 7,22,04,000 as on 31st March, 2023 and has a Paid-up Share Capital of Rs 3,00,03,000 and a Net Worth of Rs 6,30,92,660 as on March 31, 2023. The requirement of filling of Related Party Transactions is not applicable on the Company for half year ended September 30, 2023 as per Regulation 15(2) of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015, as the Paid-Up Equity Share Capital not exceeding Rupees Ten crore and Net Worth not exceeding Rupees Twenty-Five Crore, as on the last day of the previous financial year.

The above information is a part of company’s filings submitted to BSE.

Brawn Biotech Share Price

20.80 -1.05 (-4.81%)
30-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 215.90
Adani Enterprises 2404.05
Amrapali Industries 18.00
Rashi Peripheral 458.60
PDS 274.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×